Lo J, Chandra M, Khan M, Barzilay J, Carbone L, Ott S
Osteoporos Int. 2025; .
PMID: 39915333
DOI: 10.1007/s00198-024-07372-2.
Guillemot J, Abraham J, Tinker A
Front Med (Lausanne). 2025; 11:1454150.
PMID: 39871840
PMC: 11770036.
DOI: 10.3389/fmed.2024.1454150.
Sun C, He W, Wang L, Hao T, Yang X, Feng W
Cell Biochem Biophys. 2024; .
PMID: 39586961
DOI: 10.1007/s12013-024-01621-1.
Awad M, Taylor-Diaz E, Tawfik A, Hussein K, Elmansi A, Elashiry M
Bone Rep. 2024; 23:101812.
PMID: 39583183
PMC: 11585646.
DOI: 10.1016/j.bonr.2024.101812.
du Mont S, Barkmann R, Damm T, Pena J, Reinhold S, Both M
Calcif Tissue Int. 2024; 115(5):552-561.
PMID: 39414713
PMC: 11531420.
DOI: 10.1007/s00223-024-01303-3.
Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review.
Collins L, Ronan A, Hutcheon E, Ebeling P, Grill V, Nguyen H
J Bone Miner Res. 2024; 39(12):1722-1734.
PMID: 39348435
PMC: 11638334.
DOI: 10.1093/jbmr/zjae159.
Development of self-administered questionnaire on barriers, prescription practices, and guideline adherence of osteoporosis management among tertiary care clinicians: content validity and reliability analysis.
Muhamad Jamil N, Naina Mohamed I, Mokhtar S, Leong J, Kamudin N, Muhammad N
Front Endocrinol (Lausanne). 2024; 15:1393500.
PMID: 39309106
PMC: 11412838.
DOI: 10.3389/fendo.2024.1393500.
An electronic health record (EHR)-based risk calculator can predict fractures comparably to FRAX: a proof-of-concept study.
Jain R, Polley E, Weiner M, Iwamaye A, Huang E, Vokes T
Osteoporos Int. 2024; 35(12):2117-2126.
PMID: 39147872
DOI: 10.1007/s00198-024-07221-2.
Microbial Tryptophan Metabolites Ameliorate Ovariectomy-Induced Bone Loss by Repairing Intestinal AhR-Mediated Gut-Bone Signaling Pathway.
Chen C, Cao Z, Lei H, Zhang C, Wu M, Huang S
Adv Sci (Weinh). 2024; 11(36):e2404545.
PMID: 39041942
PMC: 11423200.
DOI: 10.1002/advs.202404545.
Exploring practice and perspectives on shared decision-making about osteoporosis medicines in Fracture Liaison Services: the iFraP development qualitative study.
Bullock L, Manning F, Hawarden A, Fleming J, Leyland S, Clark E
Arch Osteoporos. 2024; 19(1):50.
PMID: 38898212
PMC: 11186902.
DOI: 10.1007/s11657-024-01410-6.
CRYAB suppresses ferroptosis and promotes osteogenic differentiation of human bone marrow stem cells via binding and stabilizing FTH1.
Tian B, Li X, Li W, Shi Z, He X, Wang S
Aging (Albany NY). 2024; 16(10):8965-8979.
PMID: 38787373
PMC: 11164484.
DOI: 10.18632/aging.205851.
Local application of zoledronate inhibits early bone resorption and promotes bone formation.
Hsieh M, Wang C, Kao F, Su H, Chen M, Tsai T
JBMR Plus. 2024; 8(5):ziae031.
PMID: 38606146
PMC: 11008729.
DOI: 10.1093/jbmrpl/ziae031.
Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
Qiu S, Dhaliwal R, Divine G, Warner E, Rao S
J Bone Miner Res. 2024; 39(4):417-424.
PMID: 38477744
PMC: 11262150.
DOI: 10.1093/jbmr/zjae018.
The performance of artificial intelligence chatbot large language models to address skeletal biology and bone health queries.
Cung M, Sosa B, Yang H, McDonald M, Matthews B, Vlug A
J Bone Miner Res. 2024; 39(2):106-115.
PMID: 38477743
PMC: 11184616.
DOI: 10.1093/jbmr/zjad007.
Fully automated CT imaging biomarkers for opportunistic prediction of future hip fractures.
Liu D, Garrett J, Perez A, Zea R, Binkley N, Summers R
Br J Radiol. 2024; 97(1156):770-778.
PMID: 38379423
PMC: 11027263.
DOI: 10.1093/bjr/tqae041.
The incremental risk of fragility fractures in aging men.
Agarwal A, Tarawneh O, Cohen J, Gu A, Moseley K, DeBritz J
Osteoporos Int. 2023; 35(3):495-503.
PMID: 37938405
DOI: 10.1007/s00198-023-06956-8.
Pathophysiology of Medication-Related Osteonecrosis of the Jaw-A Minireview.
Tetradis S, Allen M, Ruggiero S
JBMR Plus. 2023; 7(8):e10785.
PMID: 37614299
PMC: 10443081.
DOI: 10.1002/jbm4.10785.
Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
Billington E, Miyagishima R, Hasselaar C, Arain M
Osteoporos Int. 2023; 34(12):2069-2076.
PMID: 37608123
DOI: 10.1007/s00198-023-06890-9.
Dark-field X-ray imaging for the assessment of osteoporosis in human lumbar spine specimens.
Gassert F, Urban T, Kufner A, Frank M, Feuerriegel G, Baum T
Front Physiol. 2023; 14:1217007.
PMID: 37534364
PMC: 10393038.
DOI: 10.3389/fphys.2023.1217007.
Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
Paskins Z, Moult A, Corp N, Bastounis A, Davis S, Narayanasamy M
Osteoporos Int. 2023; 34(10):1711-1718.
PMID: 37294333
DOI: 10.1007/s00198-023-06806-7.
